Indexado en

Licencia y uso

Citaciones

Altmetrics

Análisis de autorías institucional

Compartir

Bioimpedance measurements on human neural stem cells as a benchmark for the development of smart mobile biomedical applications

Publicado en:World Congress On Medical Physics And Biomedical Engineering: Radiation Oncology. 72 38-47 - 2020-01-01 72(), DOI: 10.1007/978-981-13-3498-6_6

Autores: Cunha AB; Schuelke C; Heiskanen A; Asif A; Hassan YM; Keller SS; Kalvøy H; Martínez-Serrano A; Emnéus J; Martinsen ØG

Afiliaciones

Resumen

© Springer Nature Singapore Pte Ltd. 2020. Over the past 30 years, stem cell technologies matured from an attractive option to investigate neurodegenerative diseases to a possible paradigm shift in their treatment through the development of cell-based regenerative medicine (CRM). Implantable cell replacement therapies promise to completely restore function of neural structures possibly changing how we currently perceive the onset of these conditions. One of the major clinical hurdles facing the routine implementation of stem cell therapy is the limited and inconsistent benefit observed thus far. While unclear, numerous pre-clinical and a handful of clinical cell fate imaging studies point to poor cell retention and survival. Coupling the need to better understand these mechanisms while providing scalable approaches to monitor these treatments in both pre-clinical and clinical scenarios, we show a proof of concept bioimpedance electronic platform for the Agile development of smart and mobile biomedical applications like neural implants or highly portable monitoring devices.

Palabras clave